Celator Pharmaceuticals Inc. (CPXX) is all set to be acquired by Jazz Pharmaceuticals plc. (JAZZ) for $30.25 per share in cash, or approximately $1.5 billion. The offer price represents a premium of approximately 73% to the closing price of CPXX on May 27, 2016.